When Angela received her first shot at the Lombardi Comprehensive Cancer Center in early 2020, Covid-19 was months away. Far from a household name, mRNA vaccines were mostly relegated to lab studies.
Yet the jab she received was made of the same technology. A melanoma patient, Angela had…
[ad_2]
Source link
